Fast Market Research announces the availability of the new Markets and Markets report,"Sugar-Based Excipients Market - Global Forecast to 2021", on their comprehensive research portal
Boston, MA -- (SBWIRE) -- 01/05/2017 -- Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021
The global sugar excipients market is estimated to grow at a CAGR of 4.3% from 2016 to 2021, to reach USD 1,060.6 million by 2021 from USD 860.6 million in 2016. Growth in this market is primarily attributed to increasing use of co-processed excipients, rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs). However, stringent regulatory requirements leading to shortage of FDA-approved manufacturing sites can hinder their market growth to a certain extent.
Get More Details on this Report and a Full Table of Contents at Sugar-Based Excipients Market - Global Forecast to 2021
In this report, the global sugar excipients market is segmented on the basis of products, types, functionalities, formulations, and region. On the basis of products, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners. The actual sugars accounted for the largest share of the sugar excipients market in 2015, owing to its high utilization in oral formulations and pediatric formulations due to its non-toxicity and negligible reaction with drugs.
On the basis of type, powders/granules segment accounted for the largest share of the sugar excipients market. The increasing use of powders/granules in various types of formulations such as tablets, capsule, and syrups in the pharmaceutical industry is the key driver for this segment. In 2015, the fillers & diluents accounted for the largest share of global sugar excipients market, by functionality. The large share of this segment can mainly be attributed to the high utilization of fillers and diluents in the development and production of oral dosage forms. Oral formulations accounted for the largest share in this market, by formulation. Its dominance is primarily attributed to the increased use of oral formulations such as tablets, capsules, solutions, and emulsions for various therapeutic areas.
Geographically, the global sugar excipients market is segmented into Europe, North America, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the global sugar excipients market. Factors such as increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region are contributing to the large share of Europe. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, favorable government policies, and low-cost manufacturing advantage in this region.
Some of the prominent players in the sugar excipients market include Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), Ashland Inc. (U.S.), Archer Daniels Midland (ADM) Company (U.S.), MEGGLE AG (Germany), Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), and The Lubrizol Corporation (U.S.).
The report analyzes the product offerings provided by sugar excipient manufacturers across different regions. It aims at estimating the market size and future growth potential of the sugar excipients market for different segments such as products, types, functionalities, formulations, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
-Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sugar excipients market. The report analyzes the sugar excipients market by product, type, functionality, formulation, and region
-Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the sugar excipients market
-Market Development: Comprehensive information about the lucrative emerging markets
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
-Pharmaceutical Excipients Market - Global Forecast to 2021
-Superdisintegrants Market - Global Forecast to 2021
-Contract Research Organizations (CROs) Services Market - Global Forecast to 2021
-Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics
-Empty Capsules Market - Global Forecast to 2021